Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2000 Jun;108(6):575–577. doi: 10.1289/ehp.00108575

A cluster of pediatric metallic mercury exposure cases treated with meso-2,3-dimercaptosuccinic acid (DMSA)

J Forman 1, J Moline 1, E Cernichiari 1, S Sayegh 1, J C Torres 1, M M Landrigan 1, J Hudson 1, H N Adel 1, P J Landrigan 1
PMCID: PMC1638142  PMID: 10856034

Abstract

Nine children and their mother were exposed to vapors of metallic mercury. The source of the exposure appears to have been a 6-oz vial of mercury taken from a neighbor's home. The neighbor reportedly operated a business preparing mercury-filled amulets for practitioners of the Afro-Caribbean religion Santeria. At diagnosis, urinary mercury levels in the children ranged from 61 to 1,213 microg/g creatinine, with a geometric mean of 214.3 microg/m creatinine. All of the children were asymptomatic. To prevent development of neurotoxicity, we treated the children with oral meso-2,3-dimercaptosuccinic acid (DMSA). During chelation, the geometric mean urine level rose initially by 268% to 573.2 microg mercury/g creatinine (p<0.0005). At the 6-week follow-up examination after treatment, the geometric mean urine mercury level had fallen to 102.1 microg/g creatinine, which was 17.8% of the geometric mean level observed during treatment (p<0.0005) and 47.6% of the original baseline level (p<0.001). Thus, oral chelation with DMSA produced a significant mercury diuresis in these children. We observed no adverse side effects of treatment. DMSA appears to be an effective and safe chelating agent for treatment of pediatric overexposure to metallic mercury.

Full text

PDF
575

Images in this article

576Figure 1
on p.576

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaseth J., Jacobsen D., Andersen O., Wickstrøm E. Treatment of mercury and lead poisonings with dimercaptosuccinic acid and sodium dimercaptopropanesulfonate. A review. Analyst. 1995 Mar;120(3):853–854. doi: 10.1039/an9952000853. [DOI] [PubMed] [Google Scholar]
  2. Agocs M. M., Etzel R. A., Parrish R. G., Paschal D. C., Campagna P. R., Cohen D. S., Kilbourne E. M., Hesse J. L. Mercury exposure from interior latex paint. N Engl J Med. 1990 Oct 18;323(16):1096–1101. doi: 10.1056/NEJM199010183231603. [DOI] [PubMed] [Google Scholar]
  3. Bellinger D., Sloman J., Leviton A., Rabinowitz M., Needleman H. L., Waternaux C. Low-level lead exposure and children's cognitive function in the preschool years. Pediatrics. 1991 Feb;87(2):219–227. [PubMed] [Google Scholar]
  4. Goyer R. A., Cherian M. G., Jones M. M., Reigart J. R. Role of chelating agents for prevention, intervention, and treatment of exposures to toxic metals. Environ Health Perspect. 1995 Nov;103(11):1048–1052. doi: 10.1289/ehp.951031048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Graziano J. H. Role of 2,3-dimercaptosuccinic acid in the treatment of heavy metal poisoning. Med Toxicol. 1986 May-Jun;1(3):155–162. doi: 10.1007/BF03259834. [DOI] [PubMed] [Google Scholar]
  6. Hua M. S., Huang C. C., Yang Y. J. Chronic elemental mercury intoxication: neuropsychological follow-up case study. Brain Inj. 1996 May;10(5):377–384. doi: 10.1080/026990596124386. [DOI] [PubMed] [Google Scholar]
  7. Kostial K., Restek-Samarzija N., Blanusa M., Piasek M., Prester L., Jones M. M., Singh P. K. Racemic-2,3-dimercaptosuccinic acid for inorganic mercury mobilization in rats. J Appl Toxicol. 1997 Jan-Feb;17(1):71–74. doi: 10.1002/(sici)1099-1263(199701)17:1<71::aid-jat395>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  8. Needleman H. L., Gatsonis C. A. Low-level lead exposure and the IQ of children. A meta-analysis of modern studies. JAMA. 1990 Feb 2;263(5):673–678. [PubMed] [Google Scholar]
  9. Needleman H. L., Schell A., Bellinger D., Leviton A., Allred E. N. The long-term effects of exposure to low doses of lead in childhood. An 11-year follow-up report. N Engl J Med. 1990 Jan 11;322(2):83–88. doi: 10.1056/NEJM199001113220203. [DOI] [PubMed] [Google Scholar]
  10. Orloff K. G., Ulirsch G., Wilder L., Block A., Fagliano J., Pasqualo J. Human exposure to elemental mercury in a contaminated residential building. Arch Environ Health. 1997 May-Jun;52(3):169–172. doi: 10.1080/00039899709602882. [DOI] [PubMed] [Google Scholar]
  11. Rosenman K. D., Valciukas J. A., Glickman L., Meyers B. R., Cinotti A. Sensitive indicators of inorganic mercury toxicity. Arch Environ Health. 1986 Jul-Aug;41(4):208–215. doi: 10.1080/00039896.1986.9938335. [DOI] [PubMed] [Google Scholar]
  12. Smith R. G., Vorwald A. J., Patil L. S., Mooney T. F., Jr Effects of exposure to mercury in the manufacture of chlorine. Am Ind Hyg Assoc J. 1970 Nov-Dec;31(6):687–700. doi: 10.1080/0002889708506315. [DOI] [PubMed] [Google Scholar]
  13. Toet A. E., van Dijk A., Savelkoul T. J., Meulenbelt J. Mercury kinetics in a case of severe mercuric chloride poisoning treated with dimercapto-1-propane sulphonate (DMPS). Hum Exp Toxicol. 1994 Jan;13(1):11–16. doi: 10.1177/096032719401300103. [DOI] [PubMed] [Google Scholar]
  14. Torres-Alanís O., Garza-Ocañas L., Pineyro-Lopez A. Evaluation of urinary mercury excretion after administration of 2,3-dimercapto-1-propane sulfonic acid to occupationally exposed men. J Toxicol Clin Toxicol. 1995;33(6):717–720. doi: 10.3109/15563659509010636. [DOI] [PubMed] [Google Scholar]
  15. Warkany J. Acrodynia--postmortem of a disease. Am J Dis Child. 1966 Aug;112(2):147–156. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES